Prospective phase II study of capecitabine and temozolomide (CAPTEM) for progressive, moderately, and well-differentiated metastatic neuroendocrine tumors.
RL Fine, AP Gulati, D Tsushima, KB Mowatt, A Oprescu… - 2014 - ascopubs.org
179 Background: We found in our lab that capecitabine (CAP), the prodrug of 5-FU, and
temozolomide (TEM) were synergistic in inducing apoptosis in BON neuroendocrine tumor (NET…
temozolomide (TEM) were synergistic in inducing apoptosis in BON neuroendocrine tumor (NET…
Retinal neovascularization and hemorrhage associated with the use of imatinib (Gleevec®) in a patient being treated for gastrointestinal stromal tumor (GIST)
AP Gulati, MW Saif - Anticancer research, 2012 - ar.iiarjournals.org
Background: Gastrointestinal stromal tumor (GIST) is a mesenchymal malignancy of the
gastrointestinal tract. Imatinib mesylate (Gleevec®, ST1571, Novartis Pharmaceuticals, Basel, …
gastrointestinal tract. Imatinib mesylate (Gleevec®, ST1571, Novartis Pharmaceuticals, Basel, …
Is there a role for liver transplantation in metastatic pancreatic neuroendocrine tumors (PNET)?
AP Gulati, MW Saif - JOP. Journal of the Pancreas, 2012 - serena.unina.it
Dear Sir, recently, we published an important report on the role of radiotherapy in pancreatic
neuroendocrine tumors (PNET) consisting of our experience and the data presented at the …
neuroendocrine tumors (PNET) consisting of our experience and the data presented at the …
Prospective phase II study of inoperable pancreatic adenocarcinoma with neoadjuvant gemcitabine, docetaxel, and capecitabine (GTX).
AP Gulati, SM Schreibman, B Schrope, JA Lee… - 2014 - ascopubs.org
274 Background: Chemoradiation (CRT) is used in unresectable pancreatic cancer (PC) to
convert patients to a resectable state. Those who go to surgery can have a similar survival as …
convert patients to a resectable state. Those who go to surgery can have a similar survival as …
Prospective phase II trial of GTX in metastatic pancreatic cancer: Laboratory and clinical studies.
R Fine, Y Lee, WH Sherman, AP Gulati, PE Oberstein… - 2013 - ascopubs.org
209 Background: We found that in pancreatic cancer (PC) cells, when gemcitabine, docetaxel,
capecitabine (GTX) are given in a sequence and time specific manner, it 1) increased Bax…
capecitabine (GTX) are given in a sequence and time specific manner, it 1) increased Bax…
The efficacy and safety of the capecitabine/temozolomide (CAPTEM) regimen in the treatment of well-differentiated neuroendocrine tumors with liver metastasis after …
PE Oberstein, AP Gulati, BA Krantz, RA Moss… - 2013 - ascopubs.org
308 Background: We have observed efficacy and tolerability of the CAPTEM regimen in
pNET. We conducted a retrospective review of patients with liver metastasis from any NET, …
pNET. We conducted a retrospective review of patients with liver metastasis from any NET, …
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
…, D Flora, MD Galsky, MJ Glover, EA Griffiths, AP Gulati… - The Lancet, 2020 - thelancet.com
Background Data on patients with COVID-19 who have cancer are lacking. Here we characterise
the outcomes of a cohort of patients with cancer and COVID-19 and identify potential …
the outcomes of a cohort of patients with cancer and COVID-19 and identify potential …
Association of convalescent plasma therapy with survival in patients with hematologic cancers and COVID-19
Importance COVID-19 is a life-threatening illness for many patients. Prior studies have
established hematologic cancers as a risk factor associated with particularly poor outcomes from …
established hematologic cancers as a risk factor associated with particularly poor outcomes from …
Racial disparities in COVID-19 outcomes among black and white patients with cancer
…, AH Angevine, MH Bar, AP Gulati… - JAMA network …, 2022 - jamanetwork.com
Importance Non-Hispanic Black individuals experience a higher burden of COVID-19 than
the general population; hence, there is an urgent need to characterize the unique clinical …
the general population; hence, there is an urgent need to characterize the unique clinical …
Interplay of immunosuppression and immunotherapy among patients with cancer and COVID-19
Importance Cytokine storm due to COVID-19 can cause high morbidity and mortality and may
be more common in patients with cancer treated with immunotherapy (IO) due to immune …
be more common in patients with cancer treated with immunotherapy (IO) due to immune …